ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
Total Current Liabilities
ESSA Pharma Inc
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ESSA Pharma Inc
NASDAQ:EPIX
|
Total Current Liabilities
$3.5m
|
CAGR 3-Years
21%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Total Current Liabilities
$55.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Current Liabilities
$39.1m
|
CAGR 3-Years
53%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Current Liabilities
$16.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Current Liabilities
$71.1m
|
CAGR 3-Years
50%
|
CAGR 5-Years
61%
|
CAGR 10-Years
32%
|
|
Spectral Medical Inc
TSX:EDT
|
Total Current Liabilities
CA$10.2m
|
CAGR 3-Years
52%
|
CAGR 5-Years
76%
|
CAGR 10-Years
11%
|
See Also
What is ESSA Pharma Inc's Total Current Liabilities?
Total Current Liabilities
3.5m
USD
Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Total Current Liabilities amounts to 3.5m USD.
What is ESSA Pharma Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
0%
Over the last year, the Total Current Liabilities growth was 22%. The average annual Total Current Liabilities growth rates for ESSA Pharma Inc have been 21% over the past three years .